Innovation
- University Of Miami School Of Medicine
The dissemination of the I-Corps@NCATS program has accelerated the development and commercialization of breakthrough innovations in medical research across U. Miami and the CTSA partner hubs. Taking the lessons from the “I-Corps at the CTSA Train-The-Trainer pilot initiative” in 2017, nine participants developed the I-Corps@NCATS program with support from a CTSA Administrative Supplement to
- Trial Innovation Network
Daniel Benjamin, MD, PhD, MPH1; Gordon R. Bernard, MD2; J. Michael Dean, MD, MBA3; Daniel E. Ford, MD, MPH4; Daniel Hanley, MD4; Paul A. Harris, PhD, FACMI2; Harry Selker, MD, MSPH5; Consuelo H. Wilkins, MD, MSCI2 1Duke Clinical Research Institute, 2Vanderbilt Institute for Clinical and Translational Research, 3University of Utah, 4Johns Hopkins University, 5Tufts University ABSTRACT: The Trial
-NCATSHarnessing NCATS SBIR/STTR Funding to Support Commercialization for Innovations in Translational Sciences Wednesday, October 27th, 2021, 1:00 – 2:00 p.m. ET Join Medical University of South Carolina (MUSC) in collaboration with the National Center for Advancing Translational Sciences (NCATS) on Wednesday, October 27, 2021, for a webinar to learn about the Small Business Innovation Research and
September 27, 2021OHSU startup, Inherent Targeting, is among the Pacific Northwest-based startups selected to present at the Pacific Northwest Startup Showcase & Social on Tuesday, October 12 from 10am-12pm. Inherent Targeting improves surgical outcomes with high contrast, nerve-specific fluorescent dyes that help surgeons visualize buried nerves and distinguish them from surrounding tissue. This reduces patient
September 02, 2021In 2020, the Oregon Clinical & Translational Research Institute (OCTRI) awarded Jessica Grant, an OHSU speech therapist, and David Sheridan, MD, an OCTRI Scholar and OHSU associate professor of emergency medicine, a Biomedical Innovation Program award for their device called the Koala Kushion. This week, the duo was interviewed for OHSU's Innovator Spotlight series. Read more about their progress
-University Of North Carolina Chapel HillThe Catalyze Program, established by NHLBI and run by Research Triangle Institute (RTI) International, transforms basic science discoveries into viable therapeutics, devices, and diagnostics. While the actual Catalyze Program is focused on products for heart, lung, blood, and sleep disorders, the information presented in these monthly seminars is foundational knowledge about product development
July 26, 2021In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced three new funded projects for the 2021 drug discovery track of the Biomedical Innovation Program. This program supports drug discovery platforms and early-stage therapeutic technology
July 23, 2021The CCTSI responded to the pandemic by issuing a rapid-release RFA to address COVID-19. CCTSI leaders called it the COVID-19-Rapid Research Pilot Program. They released the RFA on Monday evening, March 30 and closed the application process just four days later. This new pilot grant program supported the development of novel diagnostic and treatment methods and innovative technologies related to
- Journal of Clinical and Translational Science
The recipients of NIH Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research.
March 08, 2021OCTRI Scholar Dr. David Sheridan (left) and Dr. Matthew Hansen (right), both OHSU Emergency Medicine physicians, were awarded OCTRI Biomedical Innovation Program (BIP) funding and project support in 2018 to develop a new bedside technology for quickly detecting sepsis using an accurate and objective measure of capillary refill time (CRT). In the last 3 years, Drs. Sheridan and Hansen leveraged
January 21, 2021The VCU Wright Center and its researchers were featured in an MCV Foundation magazine article about how the university and health system adapted to the COVID-19 pandemic last year. Petri dishes and slides were frozen. Study plans were amended. Some research pivoted. And more than 50 new projects at Virginia Commonwealth University emerged to combat the new virus on multiple fronts. Research
December 22, 2020In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced four new funded projects for the 2021 device and diagnostics track of the Biomedical Innovation Program. This program cultivates, evaluates, and funds promising translational projects
University Of California DavisThe UC Davis CTSC applied the CTSA program goals to assist the division of pulmonary and sleep medicine with the recruitment, examination, and treatment of a diverse array of participants into an industry-funded COVID-19 vaccine trial. The project encompassed all five of the CTSA program goals and resulted in a robust study population. The first 80 subjects were recruited, screened, and scheduled
August 07, 2020The Oregon Clinical & Translational Clinical Research Institute (OCTRI) at Oregon Health & Science University (OHSU) funded three projects for their 2020 Biomedical Innovation Program drug discovery track. The funded research covers pancreatic cancer, prostate cancer, and SARS-CoV-2. This category of funding supports drug discovery platforms and early-stage therapeutic technology projects
June 18, 2020OCTRI announces six awardees to two tracks of the Biomedical Innovation Program: COVID-19 Rapid Response and Digital Health.
April 13, 2020The Oregon Clinical & Translational Research Institute (OCTRI) at Oregon Health & Science Universtiy (OHSU) pivoted rapidly to support our home institution and our state during this crisis. Our rapid response allowed us to become the central organizing and triage hub for clinical research during this time. This provided us the opportunity to demonstrate our value to OHSU and also to utilize the
January 29, 2020Dr. David Sheridan, Assistant Professor of Emergency Medicine, and his team at Oregon Health & Science University are developing a wearable device that assesses and reports the physiological measures associated with stress dysregulation and worsening suicidality. The goal is to help adolescents identify these symptoms and therefore allow time for interventions that can help prevent emergency- ACS Pharmacology & Translational Science
Translational science is defined as the field of investigation focused on understanding the scientific and operational principles underlying each step of the translational process. Further development of the field is advanced by describing the key desirable characteristics of individuals who seek to uncover these principles to increase the efficiency and efficacy of translation.
University Of PennsylvaniaAcademic Entrepreneurship for Medical and Health Scientists, is a free open education resource that can be used in courses, workshops, pilot grant programs, and by individuals. Who is an academic entrepreneur? Faculty, staff, or students turning observations in the laboratory, clinic, and community into interventions that improve the health of individuals and the public and seeking to: patent and
Columbia University Health SciencesThe Columbia Lab-to-Market: Life Science Accelerator Program comprised of the Translational Therapeutics Accelerator (TRx), Accelerating Cancer Therapeutics (ACT), and the Biomedical Technology Accelerator (BiomedX). About the Course: This course is a series of evening sessions designed to provide specialized frameworks and essential tools to investigator teams (clinicians, engineers, scientists)
Emory UniversityThe goal of CTSAs across the nation is to “get more treatments to more patients more quickly”1. One effective pathway to reach patients is via commercializing biomedical innovations. However, within an academic environment, researchers often do not have access to or experience with building the skills necessary to take an innovation to market. Hence, the Georgia CTSA opted to create a unique
University Of Pittsburgh At PittsburghThe University of Pittsburgh Clinical and Translational Science Institute (CTSI) launched the optional Innovation Core in 2015 with three aims: 1) Develop advanced, experiential innovation training, networking and externship opportunities and support the academic career development for biomedical innovators; 2) Develop and disseminate new methods and processes that encourage and support innovative
University of Minnesota Twin CitiesPediatric medical technology advancement is about a decade behind adult technology advancement. This technology lag was reflected in a lack of pediatric-specific innovation within the University of Minnesota (UMN). To address this institutional and national deficit, we developed a novel program around pediatric technology innovation. The Pediatric Health Innovation Program (PHIP) at the UMN
June 11, 2018In 2012 and 2013, Drs. Nathan Berger and Amitabh Chak, partnered with the Clinical and Translational Science Collaborative (CTSC) of Cleveland to sponsor the Barrett’s Esophagus Translational Research Network (BETRNet) Pilot Grant Program. This partnership provided translational support which ultimately helped the founders' research develop the EsoCheck technology through BETRNet.